Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders

International Journal of Neuropsychopharmacology

Volumn 6, Issue 4, 2003, Pages 409-414

  Raja, Michele ^a   Azzoni, Antonella ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Bipolar disorder; Oxcarbazepine; Schizoaffective disorder; Treatment; Valproate

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CHLORPROMAZINE; DIAZEPAM; LITHIUM; NEUROLEPTIC AGENT; OXCARBAZEPINE; PSYCHOTROPIC AGENT; VALPROIC ACID;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; ARTICLE; BARNES AKATHISIA SCALE; BRPS ANXIETY DEPRESSION CLUSTER; BRPS HOSTILITY SUSPICIOUSNESS CLUSTER; CLINICAL ARTICLE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; MORRISON SCALE; NEGATIVE SYNDROME; OPEN STUDY; OUTCOMES RESEARCH; POSITIVE SYNDROME; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS; SCHIZOAFFECTIVE PSYCHOSIS; SCORING SYSTEM; UNIFIED PARKINSON DISEASE RATING SCALE; UPDRS TREMOR ITEM;

ADULT; AKATHISIA, DRUG-INDUCED; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CARBAMAZEPINE; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PERSONALITY INVENTORY; PSYCHOTIC DISORDERS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0742288277     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145703003754     Document Type: Article

References (12)

1. Dietrich DE, Kropp S, Emrich HM (2001). Oxcarbazepine in affective and schizoaffective disorders. Pharmacopsychiatry 34, 242-250.
2. APA (2002). Practice guidelines for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry 159 (Suppl. 4), 1-50.
3. Emrich HM (1990). Studies with oxcarbazepine (Trileptal) in acute mania. International Clinical Psychopharmacology 5, 83-88.
4. Emrich HM (1994). Experience with oxcarbazepine in acute mania. In: Modigh K, Robak OH, Vestergaard P (Eds.), Anticonvulsants in Psychiatry (pp. 29-36). Whrigtson Biomedical Publishing, Petersfield.
5. Emrich HM, Dose M, von Zerssen D (1984). Action of sodium-valproate and of oxcarbazepine in patients with affective disorders. In: Emrich HM, Okuma T, Müller AA (Eds.), Anticonvulsants in Affective Disorders (pp. 45-55). Amsterdam: Excerpta Medica.
6. Emrich HM, Dose M, von Zerssen D (1985). The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. Journal of Affective Disorders 8, 243-250.
7. Hummel B, Walden J, Stampfer R, Dittman S, Amann B, Sterr A, Schaefer M, Frye MA, Grunze H (2002). Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Bipolar Disorder 4, 412-417.
8. Morrison EF (1992). A hierarchy of aggressive and violent behaviors among psychiatric inpatients. Hospital and Community Psychiatry 43, 505-506.
9. Müller AA, Stoll KD (1984). Carbamazepine and oxcarbazepine in the treatment of manic syndrome - Studies in Germany. In: Emrich HM, Okuma T, Müller AA (Eds.), Anticonvulsants in Affective Disorders (pp. 139-147). Amsterdam: Elsevier.
10. Shorvon S (2000). Oxcarbazepine: a review. Seizure 9, 75-79.
11. Suppes T, Dennehy EB, Swann AC, Bowden CL, Calabrese JR, Hirschfeld RMA, Keck Jr. PE, Sachs GS, Crismon ML, Toprac MG, Shon SP, for the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder (2002). Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000. Journal of Clinical Psychiatry 63, 288-299.
12. Velikonja M, Heinrich K (1984). Effect of oxcarbazepine (GP 47.680) on affective and schizoaffective symptoms: a preliminary report. In: Emrich HM, Okuma T, Müller AA (Eds.), Anticonvulsants in Affective Disorders (pp. 208-210). Amsterdam: Elsevier.